Reform bill would reveal fees firms pay to doctors
A proposal requiring drug and medical-device companies to disclose their often-controversial consulting agreements with doctors is now part of healthcare legislation unveiled before the Senate Finance Committee. The provision is tucked within an $856 billion healthcare overhaul that was introduced by Sen. Max Baucus, the committee's chairman. The legislation calls for drug and medical device companies to file annual reports showing payments to doctors for services such as marketing, education and research beginning March 31, 2012. The information would be available to the public on the Internet.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- 4 Tips for Managing Employed Physicians
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- Providers Ask HHS to Address EHR Interoperability Barriers